Revlimid Lawsuit News and Information
Revlimid Lawsuits
The blood-cancer drug Revlimid has been associated with the development of rare and potentially fatal skin reactions known as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
All Articles Tagged With: "Revlimid"
Treanda Stevens-Johnson Syndrome Cases Lead to New Warnings
According to Cephalon, Inc., at least two users of their cancer drug Treanda developed a severe form of the skin condition Stevens-Johnson syndrome, known as toxic epidermal necrolysis, and at least one has died. As a result, the drug’s warning label will be updated about the risk of using the drug in combination with allopurinol. [...]
Revlimid Stevens-Johnson Syndrome Warning Could be Added
According to drug maker Celgen Corp., the FDA will likely update the warning label for their blood-cancer drug Revlimid to indicate that side effects of the medication could lead to potentially fatal skin reactions such as Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN).
Contact a Lawyer
Submit information about your potential case to be reviewed by an attorney.
